November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreOctober 14, 2025
The global marine pharmaceuticals market was valued at USD 6.19 B in 2024 and is projected to reach USD 10.34 B by 2034 at a 5.29% CAGR. Covers NA, EU, APAC, LA, MEA, with full segmentation, trade, manufacturer, and supplier data. Regional data across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa is presente...
October 14, 2025
The artificial blood substitute market is USD 11.67 million in 2025, projected to reach USD 62.54 million by 2034 at 20.45% CAGR. North America leads (38% share), Asia-Pacific grows fastest. Key segments: plasma/volume expanders (35%), trauma care (40%), hospitals (60%). Covers companies, competitive analysis, value chain, trade, and regional ins...
October 14, 2025
According to forecasts, the global berberine API market will grow from USD 523 million in 2024 to USD 973.13 million by 2034, with an expected CAGR of 6.45%.The berberine API market is growing due to its wide use in nutraceuticals, pharmaceuticals, and health supplements, as it has a wide range of pharmacological effects. Asia Pacific is dominant i...
October 14, 2025
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for personalized medicines drive the global market. North America dominated due to the availability of st...
October 13, 2025
Projections indicate that, travel vaccination service industry is projected to rise from USD 4.69 billion in 2024 to USD 11.99 billion by 2034, reflecting a CAGR of 9.85% over the next decade. The rising prevalence of infectious disorders and increasing international travel bolster market growth. Favorable government support and a robust healthcare...
October 13, 2025
According to forecasts, the Europe cell and gene therapy market will grow from USD 2.74 billion in 2024 to USD 48.96 billion by 2034, with an expected CAGR of 23.90%. The Europe cell and gene therapy market is growing due to the growing incidence of genetic diseases and enhanced regulatory frameworks....
October 13, 2025
According to forecasts, the North America cell and gene therapy market will grow from USD 9.19 billion in 2024 to USD 79.01 billion by 2034, with an expected CAGR of 24.01%. The North America cell and gene therapy market is growing due to the rising demand for highly specific therapeutics for genetic disorders....
October 13, 2025
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending....
October 13, 2025
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
October 10, 2025
Projections indicate that, Middle East and Africa life science industry is projected to rise from USD 4.47 billion in 2024 to USD 13.07 billion by 2034, reflecting a CAGR of 11.32% over the next decade. The market is expanding due to rising R&D investments, technological advancements, and growing demand for precision medicine. In the Middle Eas...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com